Board Member
Associate Board
Morgan Cheatham is an investor with Bessemer Venture Partners where he focuses on applications of artificial intelligence in healthcare, marketplaces, and enterprise software from the seed to growth stages.
 
Before joining Bessemer, Mr. Cheatham worked at Goldman Sachs in the Consumer Retail and Healthcare Group in the Investment Banking Division. He also worked as a data scientist at Kyruus, a healthcare IT startup focused on patient access and provider data management.
 
Mr. Cheatham was accepted to Brown Medical School at age 17 and Harvard Business School at age 21. He graduated magna cum laude from Brown University with a degree in Neuroeconomics.
Let's spread the word about Immunotherapy! Click to share this page with your community.

*Immunotherapy results may vary from patient to patient.

Top